Morgan Stanley
-
-
-
-
-
-
-
Quest Diagnostics to Speak at the Morgan Stanley 20th Annual Global Healthcare Conference
-
-
-
-
-
-
-
Morgan Stanley Upgrades Quest Diagnostics (DGX) to Overweight; to Benefit from Shifts to Phase II of COVID-19 Testing
-
-
-
-
-
-
-
Quest Diagnostics (DGX) PT Lowered to $101 at Morgan Stanley
-
-
-
-
-
-
-
Maverick Capital 13F Shows New Stakes in Blue Buffalo Pet (BUFF), Dollar General (DG), Increase in ABI (BUD), Philip Morris (PM), (More...)
-
-
-
-
-
-
-
Notable Analyst Rating Changes 07/09: (S) (HPQ) (YY) Upgraded; (NEM) (ISRG) (IBM) Downgraded
-
-
-
-
-
-
-
Daily State of the Markets 01/31: Lots of Excuses, But...
-
-
-
-
-
-
-
Morgan Stanley Downgrades Quest Diagnostics (DGX) to Underweight
-
211,042 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

